Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomic Analysis of 6-mercaptopurine in Pediatric Acute Lymphoblastic Leukemia

NCT04770922 is registered in ClinicalTrials.gov with Cipherome, Inc. as lead sponsor.

NCT NCT04770922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04770922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomic Analysis of 6-mercaptopurine in Pediatric Acute Lymphoblastic Leukemia
Lead sponsor
Cipherome, Inc.
Phase
Observational
Overall status
Completed
Start date
February 23, 2021
Completion date
November 10, 2021
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, pediatric, adverse drug event